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Credentialing and training of CREST stentors
Thomas L. Forbes, MD, London, Ontario, CanadaA report describing the credentialing and training of
stentors in the Carotid Revascularization Endarterectomy
vs Stenting Trial (CREST) was recently presented at the
2009 International Stroke Conference of the American
Heart Association (San Diego, Calif, Feb 18-20, 2009).1
CREST is an ongoing randomized clinical trial com-
paring carotid endarterectomy and carotid artery stenting
(CAS) in stroke prevention. To limit the learning curve
effect, trial investigators have adopted a two-step creden-
tialing and training algorithm. Initially, prospective inves-
tigators submit data on their most recent 10 to 30 con-
secutive CAS cases to a multidisciplinary interventional
management committee (IMC). If approved by the IMC,
candidates enter a lead-in credentialing phase with animal
training or didactic and hands-on training, or both, before
performing up to 20 CAS lead-in cases for review by the
IMC. After final approval, operators may enroll patients in
the randomized phase. The IMC does have the prerogative
to exempt operators from the lead-in phase if they have
demonstrated sufficient CAS experience in other trials.
Of the 429 operators who applied, 225 (52%) were
eventually approved for randomization. Initially, 117 oper-
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were exempted from the lead-in phase because of prior
experience. Of the 198 operators approved for the lead-in
phase, 40% were cardiologists and 21% were vascular sur-
geons, and 160 were approved for the randomization phase
after completing an average of nine CAS cases (range, 1-35)
in the lead-in phase. A total of 225 operators from 122 sites
have been approved.
The CREST investigators conclude that this process is
more rigorous than those in other CAS trials and should
reduce the learning curve effects.
COMMENTARY
The CREST investigators attempt to alleviate concerns
about stent operator experience by outlining their creden-
tialing and training process. Half of those who originally
applied were approved to participate in the randomization
phase. The largest number of participants was cardiologists
(40%), with vascular surgery represented by 21% of opera-
tors.
Whether this process results in improved stenting out-
comes remains to be seen. Interestingly, there is no such
process for those performing endarterectomy despite the
well-documented training-volume-outcome relationship.
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